WallStSmart
SMMT

Summit Therapeutics PLC

NASDAQ: SMMT · HEALTHCARE · BIOTECHNOLOGY

$21.46
+3.02% today

Updated 2026-04-30

Market cap
$16.50B
P/E ratio
P/S ratio
3,891.31x
EPS (TTM)
$-1.44
Dividend yield
52W range
$14 – $31
Volume
3.1M

Summit Therapeutics PLC (SMMT) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-5.96M$-16.13M$-14.72M$-2.65M$-4.33M$-2.44M$-3.19M$-5.57M$-11.01M$-17.18M$15.18M$-20.79M$-35.14M$-26.66M$-48.11M$-72.59M$-41.58M$-76.76M$-142.11M$-322.93M
Capital expenditures$3.37M$3.86M$1.65M$140588.00$193065.00$190006.00$120042.00$77527.00$52734.00$93997.00$109995.00$678009.00$163945.00$265327.00$421000.00$306000.00$624000.00$128000.00$139000.00$657000.00
Depreciation
Stock-based comp$792452.00$966414.00$305554.00$-28756.00$117105.00$97358.00$181643.00$226000.00$1.45M$1.65M$1.72M$2.27M$6.22M$542049.00$1.29M$12.80M$12.15M$14.11M$50.98M$732.42M
Free cash flow$-9.33M$-19.99M$-16.37M$-2.79M$-4.53M$-2.63M$-3.31M$-5.65M$-11.06M$-17.28M$15.07M$-21.47M$-35.31M$-26.93M$-48.53M$-72.89M$-42.21M$-76.89M$-142.25M$-323.59M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$0.00$0.00$0.00$0.00